Literature DB >> 15304353

Phosphorylated alpha-synuclein in normal mouse brain.

Yu Hirai1, Shinobu C Fujita, Takeshi Iwatsubo, Masato Hasegawa.   

Abstract

alpha-Synuclein phosphorylated at Ser129 is the main component of Lewy bodies of Parkinson's and closely related diseases. We studied, by quantitative immunoblotting, changes in the phosphorylation level of alpha-synuclein in the mouse brains subjected to cold water stress. Relative basal level of alpha-synuclein phosphorylation at Ser129 was 40% higher in the striatum compared with the hippocampus. The phosphorylation level decreased to 57% in the striatum 20 min after 5 min of cold water stress, and also in the hippocampus and cortex to lesser degrees. Recovery to basal levels took place over several hours. The stress-induced temporary dephosphorylation was of smaller magnitude in the striatum of aged (18 months) mice. These results show that alpha-synuclein phosphorylation level at Ser129 in vivo responds to physiological stimuli. Relative prominence and age sensitivity of this phenomenon in the striatum may be relevant to the pathogenesis of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304353     DOI: 10.1016/j.febslet.2004.07.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  14-3-3eta is a novel regulator of parkin ubiquitin ligase.

Authors:  Shigeto Sato; Tomoki Chiba; Eri Sakata; Koichi Kato; Yoshikuni Mizuno; Nobutaka Hattori; Keiji Tanaka
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

2.  Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner.

Authors:  Youhei Machiya; Susumu Hara; Shigeki Arawaka; Shingo Fukushima; Hiroyasu Sato; Masahiro Sakamoto; Shingo Koyama; Takeo Kato
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

3.  Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context.

Authors:  Vicente Sancenon; Sue-Ann Lee; Christina Patrick; Janice Griffith; Amy Paulino; Tiago F Outeiro; Fulvio Reggiori; Eliezer Masliah; Paul J Muchowski
Journal:  Hum Mol Genet       Date:  2012-02-21       Impact factor: 6.150

4.  Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

Authors:  Katerina E Paleologou; Adrian W Schmid; Carla C Rospigliosi; Hai-Young Kim; Gonzalo R Lamberto; Ross A Fredenburg; Peter T Lansbury; Claudio O Fernandez; David Eliezer; Markus Zweckstetter; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

5.  Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.

Authors:  Haiyan Lou; Susana E Montoya; Tshianda N M Alerte; Jian Wang; Jianjun Wu; Xiangmin Peng; Chang-Sook Hong; Emily E Friedrich; Samantha A Mader; Courtney J Pedersen; Brian S Marcus; Alison L McCormack; Donato A Di Monte; S Colette Daubner; Ruth G Perez
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

6.  Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.

Authors:  Hui-Ming Gao; Paul T Kotzbauer; Kunihiro Uryu; Susan Leight; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2008-07-23       Impact factor: 6.167

7.  Initiation of Parkinson's disease from gut to brain by δ-secretase.

Authors:  Eun Hee Ahn; Seong Su Kang; Xia Liu; Guiqin Chen; Zhentao Zhang; Bindu Chandrasekharan; Ashfaqul M Alam; Andrew S Neish; Xuebing Cao; Keqiang Ye
Journal:  Cell Res       Date:  2019-10-24       Impact factor: 25.617

Review 8.  Proteolytic α-Synuclein Cleavage in Health and Disease.

Authors:  Alexandra Bluhm; Sarah Schrempel; Stephan von Hörsten; Anja Schulze; Steffen Roßner
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

9.  Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.

Authors:  Liyan Qiao; Shusei Hamamichi; Kim A Caldwell; Guy A Caldwell; Talene A Yacoubian; Scott Wilson; Zuo-Lei Xie; Lisa D Speake; Rachael Parks; Donna Crabtree; Qiuli Liang; Stephen Crimmins; Lonnie Schneider; Yasuo Uchiyama; Takeshi Iwatsubo; Yi Zhou; Lisheng Peng; YouMing Lu; David G Standaert; Ken C Walls; John J Shacka; Kevin A Roth; Jianhua Zhang
Journal:  Mol Brain       Date:  2008-11-21       Impact factor: 4.041

10.  In vitro phosphorylation does not influence the aggregation kinetics of WT α-synuclein in contrast to its phosphorylation mutants.

Authors:  Sarah Schreurs; Melanie Gerard; Rita Derua; Etienne Waelkens; Jean-Marc Taymans; Veerle Baekelandt; Yves Engelborghs
Journal:  Int J Mol Sci       Date:  2014-01-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.